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Summary 
  A new inhibitor, H-Ala-Ile-pyrrolidin-2-yl boronic acid, was developed as an 
inhibitor against prolyl tripeptidyl aminopeptidase with the Ki value of 88.1 nM. The 
structure of the prolyl tripeptidyl aminopeptidase complexed with the inhibitor 
(enzyme-inhibitor complex) was determined at 2.2 Å resolution. The inhibitor was 
bound to the active site through a covalent bond between Ser603 and the boron atom 
of the inhibitor. This structure should closely mimic the structure of the 
reaction-intermediate between the enzyme and substrate.  
We previously proposed that two glutamate residues, Glu205 and Glu636, are 
involved in the recognition of substrates. In order to clarify the function of these 
glutamate residues in substrate recognition, three mutant enzymes, E205A, E205Q, 
and E636A were generated by site-directed mutagenesis. The E205A mutant was 
expressed as an inclusion body. The E205Q mutant was expressed in soluble form, but 
no activity was detected for it. 
  Here, the structures of the E636A mutant and its complex with the inhibitor were 
determined. The inhibitor was located at almost the same position as in the wild-type 
enzyme-inhibitor complex. The amino group of the inhibitor interacted with Glu205 
and the main-chain carbonyl group of Gln203. In addition, a water molecule in the 
place of Glu636 of the wild-type enzyme interacted with the amino group of the 
inhibitor. This water molecule was located near the position of Glu636 in the wild 
type and formed a hydrogen bond with Gln203. The kcat/KM values of the E636A 
mutant toward the two substrates used were smaller than those of the wild type by two 
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orders of magnitude. The Ki value of our inhibitor for the E636A mutant was 48.8 M, 
which was 554-fold higher than that against the wild-type enzyme. Consequently, it 
was concluded that Glu205 and Glu636 are significant residues for the N-terminal 
recognition of a substrate. 
 
Keywords: prolyl tripeptidyl aminopeptidase, peptidase family S9, serine enzyme, 
substrate-recognition mechanism, crystal structure 
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INTRODUCTION 
The Gram-negative anaerobe Porphyromonas gingivalis is a major pathogen 
associated with adult periodontitis. P. gingivalis possesses a complex proteolytic 
system, which is very important for its growth and evasion of host defense 
mechanisms 1-3.  
Prolyl tripeptidyl aminopeptidase (PTP) from P. gingivalis was first identified by 
Banbula and colleagues 4. PTP belongs to the family S9, also known as the prolyl 
oligopeptidase (POP) family, which includes, among other members, POP, dipeptidyl 
aminopeptidase IV (DPIV), acylaminoacyl peptidase, and oligopeptidase B. POP 
family enzymes have an Asp-His-Ser catalytic triad occuring in the order of 
Ser-Asp-His in the primary sequence, with the catalytic serine located within the 
Gly-X-Ser-X-Gly motif. These features are indications of an /-hydrolase topology 
5.  
PTP releases a tripeptide Xaa-Xaa-Pro from substrates possessing an N-terminal 
free amino group and proline residue at the third position from the N-terminus. The 
enzyme is a homodimer of subunits whose molecular weight is approximately 82,300 
and is a type II membrane-bound enzyme. In order to clarify the substrate-recognition 
mechanism of PTP, we have investigated the enzyme using kinetics and X-ray 
crystallography.  
Recently, we determined the crystal structures of PTP with an N-terminal 
truncation of 38 residues (PTP39) and its S603A mutant enzyme complexed with the 
substrate, Gly-Ala-Pro-β-naphthylamide (-βNA), at 2.1 and 2.9 Å resolution, 
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respectively 6. The subunit of the enzyme is composed of two domains, the N-terminal 
eight-bladed β-propeller domain (Glu45–Lys470) and the C-terminal catalytic domain 
(Asn471–Leu732). The active site is located in a large cavity between the two 
domains. The overall structure of PTP39 was similar to those of mammalian DPIV 
(PDB code: 1JQP, 1N1M, 1ORV and 1ORW) that release a dipeptide from an 
oligopeptide with a proline as the second residue from the N-terminus. In DPIV, the 
N-terminal amino group of a substrate is recognized by two glutamate residues from 
the N-terminal β-propeller domain, Glu205 and Glu206. In PTP39, however, only 
Glu205 corresponding to Glu206 in DPIV was conserved. It was considered that 
Glu636, which belongs to the catalytic domain, is specifically involved in the 
recognition of the N-terminal amino group of substrates.  
A specific inhibitor would be not only a useful tool for the analysis of catalytic 
mechanism but could also serve as a starting template for potential drug development. 
Several inhibitors have been synthesized for proline-specific peptidases, and the 
structures of their enzyme-inhibitor complexes have been analyzed: prolyl 
aminopeptidase with 5-Prolyl-2-tert-butyl-[1, 3, 4]-oxadiazole (Pro-TBODA), 
Ala-TBODA, and Sarcosinyl-TBODA 7, 8; POP with Z-Pro-prolinal 9; DPIV with 
diprotin A 10, 1-(2S-cyanopyrrolidin-1-yl)-3-(3-iodophenyl)-1-oxopropan-2-aminium 
trifluoroacetate 11, 2-amino-3-methyl-1-pyrrolidine-1-yl-butan-1-one 12, 7-Benzyl-1, 
3-dimethyl-8-piperazin-1-yl-3, 7-dihydro-purine-2, 6-dione, tert-butyl-Gly-L-Pro-L-Ile, 
4-(2-aminoethyl)-benzene sulfonyl fluoride, and L-Pro-boro-L-Pro 13; and  
aminopeptidase P with Apstatin 14 and Pro-Leu 15. However, no specific inhibitors of 
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PTP have been developed. 
In this study, we developed a new inhibitor of PTP, H-Ala-Ile-pyrrolidine-2-yl 
boronic acid, and determined the crystal structure of its complex with the PTP39. 
Additionally, based on the crystal structure and the kinetic analysis of the E636A 
mutant, the substrate-recognition mechanism, especially the function of the Glu636 
residue, was elucidated. 
 
RESULTS 
Kinetic study of the PTP39 and E636A mutant 
Kinetic parameters were estimated using Gly-Ala-Pro-NA and Ala-Phe-Pro-NA 
as substrates (Table 1). The KM values of PTP39 toward Gly-Ala-Pro-NA and 
Ala-Phe-Pro-NA were 0.42 and 0.17 mM, respectively, and those of the E636A 
mutant were 0.38 and 0.85 mM, respectively. The KM values of the E636A mutant 
were similar to those of PTP39. However, since the kcat values of the E636A mutant 
were significantly lower, the kcat/KM values were 0.83% and 0.27% of those of PTP39 
toward Gly-Ala-Pro-NA and Ala-Phe-Pro-NA, respectively.  
 
Inhibition activity of H-Ala-Ile-pyrrolidin-2-yl boronic acid 
The Ki values of H-Ala-Ile-pyrrolidin-2-yl boronic acid for PTP39 and the E636A 
mutant were estimated using Ala-Phe-Pro-NA as a substrate, and were 88.1 nM and 
48.8 M, respectively. We also assayed the inhibition activity against prolyl 
oligopeptidase from Aeromonas hydrophila, dipeptidyl aminopeptidase IV from 
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Stenotrophomonas maltophilia and prolyl aminopeptidase from Bacillus coagulans 
using Ala-Phe-Pro-NA, Gly-Pro-NA, and Pro-NA as substrates, respectively.  
The H-Ala-Ile-pyrrolidin-2-yl boronic acid did not influence the enzyme activity of 
either dipeptidyl aminopeptidase IV or prolyl aminopeptidase at concentrations up to 
10 M. In contrast, prolyl oligopeptidase was significantly inhibited by this 
concentration, and the estimated Ki value was found to be 127 nM 
using .Z-Gly-Pro-NA as a substrate. 
 
Quality of the structure 
The refined model of PTP39 complexed with the inhibitor (PTP39-inhibitor 
complex) consisted of 659 residues, 332 water molecules, a sulfate anion, and an 
inhibitor molecule with an R-factor of 18.6% at 2.20 Å resolution. This model lacks 
the 33 N-terminal residues (12 artificial residues including His-tag and Leu39–Phe49) 
and 24 other residues (Ala77–Gln83, Glu98–Ala107, Pro472–Tyr476, and 
Ser532-Ser533) due to the lack of an unequivocal Fourier map. Alanine models were 
applied in the case of Tyr50, Lys76, Lys470, Asn471, and Arg531, since the electron 
densities corresponding to the side chains of these residues on the Fourier map were 
weak or not observed at all. The average thermal factor of the main-chain atoms, 
water molecules, sulfate anion, and inhibitor were 41.2, 39.7, 60.6, and 31.3 Å2, 
respectively. PROCHECK 16 analysis of stereochemistry revealed that all residues 
except for Ser603 fell within the generously allowed region of the Ramachandran plot, 
with 482 residues in the most favored region, 70 residues in the additionally allowed 
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region, and 3 residues in the generously allowed region. 
The model of the E636A mutant consisted of 692 residues, 532 water molecules, a 
sulfate anion and a glycerol, and the model of E636A mutant complexed with the 
inhibitor (E636A-inhibitor complex) consisted of 639 residues, 585 water molecules, 
and the inhibitor. After refinement for the E636A mutant and the E636A-inhibitor 
complex, R-factors of 18.8 and 18.5% were given at 2.00 and 1.95 Å resolution, 
respectively. Due to the obscure Fourier map, these models of the E636A mutant and 
E636A-inhibitor complex lacked 52 residues (the 12 N-terminal artificial residues, 
Leu39–Tyr53, Ala77–Gln83, Glu98–Ala107, Asn471-Asp473, and Arg531–Val534) 
and 51 residues (the 12 N-terminal artificial residues, Leu39–Tyr53, Ala77–Gln83, 
Lys101–Thr105, Asn471-Tyr476, and Arg531–Val534), respectively. The average 
thermal factors of the main-chain atoms and water molecules at the E636A mutant 
were 35.2 and 40.6 Å2, respectively, and those of the main-chain atoms, water 




The overall structures of the PTP39-inhibitor complex, E636A mutant, and 
E636A-inhibitor complex showed no significant difference with that of PTP39 
(Figure 1). The Cα positions of the three structures could be superimposed onto that 
of PTP39 6 with root-mean-square deviations of 0.16, 0.16, and 0.16 Å, and maximum 
distances of 1.92, 1.18, and 1.50 Å, respectively. Briefly, every subunit in the 
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homodimer consists of two domains, the eight-bladed β-propeller domain 
(Pro51–Lys470) and the catalytic domain (Asn471–Leu732). The active site is 
composed of residues from both domains and is located at the large cavity in the 
side-face of the β-propeller domain. Therefore, the active site was exposed to solvent.  
 
Active site in PTP39-inhibitor complex 
The ribbon-and-stick diagram of the active site in the PTP39-inhibitor complex is 
shown in Figure 2a. The inhibitor was bound to the active site with a covalent bond 
between the hydroxyl oxygen of Ser603 and the boron atom of the inhibitor. Although 
the inhibitor was used in its racemic form, only the corresponding R-configured form 
was found bound to the active site after considering the Cα-position of the pyrrolidine 
ring. One of the hydroxyl groups of borate formed a hydrogen bond with the hydroxyl 
group of Tyr518 at a distance of 2.65 Å. We previously reported the structure of the 
S603A mutant complexed with the substrate Gly-Ala-Pro-βNA (S603A-substrate 
complex; PDB code: 2dcm)6. From the comparison between these two structures, the 
position of the inhibitor was found closer to the protein than that of the substrate 
(Figure 3a). In particular, the pyrrolidine ring of the inhibitor corresponding to the 
proline residue at the P1 position was just buried in the hydrophobic pocket composed 
of Tyr604, Val629, Trp632, Tyr635, Tyr639, Val680, and Val681. From the 
comparison with the structure of PTP39, the conformation of Tyr635 and Val680 was 
changed by the inhibitor binding, resulting in respective shifts of 0.44 and 0.36 Å to 
enlarge the hydrophobic pocket. The hydroxyl group of Tyr635 made a hydrogen 
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bond with the carbonyl oxygen of the inhibitor at the P3 position at a distance of 2.63 
Å. 
A large space was obvious as the S2 site, composed of Glu205, Phe206, Glu 336, 
Leu338, Pro521, His522, Tyr639, Tyr643, and Arg642. Two salt-bridges between the 
two domains were formed by Glu205-Arg642 and Glu336-His522. The isoleucyl 
group of the inhibitor, corresponding to the P2 position, was located in the S2 site, 
and the Cγ atom was located at distances of 3.61 and 3.70 Å from His522 and Tyr639, 
respectively.  
The N-terminal amino group of the inhibitor interacted with the side-chain carboxyl 
groups of Glu205 and Glu636 and the main-chain carbonyl group of Gln203 at 
distances of 2.61, 2.74, and 2.77 Å, respectively. Furthermore, as shown in Figure 4a, 
Glu205 formed a salt-bridge with Arg642 belonging to the catalytic domain, and 
Glu636 formed hydrogen bonds with the main-chain NH group of Tyr639 and the 
side-chain amino group of Gln203 belonging to the β-propeller domain. 
PTP39 possesses a large groove extended from the active site to the β-propeller 
domain. The groove is predominantly composed of residues from the β-propeller 
domain: Glu193-Arg204, Gln228, Lys247-Pro252, His259, and Pro679-Val680. The 
N-terminal side-chain of the inhibitor faces to this groove. Accordingly, it is 
considered that the vestibule area of the groove composed of Gln203, Arg204, and 
Val680 is the S3 site to accommodate an N-terminal side-chain. 
       
Active site in E636A mutant and E636A-inhibitor complex 
Prolyl Tripeptidyl Aminopeptidase from P. gingivalis 
 11
The positions of the residues in the active site of the E636A mutant and the 
E636A-inhibitor complex did not differ very much from those of PTP39 and the 
PTP39-inhibitor complex (Figure 3b). In spite of the alanine substitution for Glu636, 
the position of the inhibitor in the E636A mutant virtually overlapped to that in the 
PTP39-inhibitor complex. In the E636A-inhibitor complex, the N-terminal amino 
group of the inhibitor interacted with the side-chain of Glu205 and the main-chain 
carbonyl group of Gln203 at distances of 2.67 and 2.67 Å, respectively (Figure 4b). A 
water molecule was found at the position approximately corresponding to that of the 
carboxyl group of Glu636. The N-terminal amino group of the inhibitor formed a 
hydrogen bond with this water molecule, and this water molecule formed another 
hydrogen bond with the side-chain amino group of Gln203.  
 
DISCUSSION 
The inhibitor binding to the active site 
  We previously determined the structures of PTP39 and its S603A mutant 
complexed with a substrate, Gly-Ala-Pro-βNA 6. In that study, we suggested that the 
Pro residue of substrates is accommodated by a hydrophobic pocket composed of 
Tyr604, Val629, Trp632, Tyr635, Tyr639, Val680, and Val681, and that the 
N-terminal amino group is recognized by Glu205 and Glu636.  Superimpositions of 
the structures of the PTP39-inhibitor and S603A-substrate complexes onto that of 
PTP39 were performed with the least-square method. The inhibitor was bound to the 
active site with the same manner in the substrate in the S603A-substrate complex. The 
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N-terminal amino group of the inhibitor was located at a similar position to that of the 
substrate: the distance between the two relevant atoms was 0.40 Å. The N-terminal 
amino group was located at distances of 2.62, 2.73, and 2.77 Å from Glu205, Glu636, 
and the main-chain carbonyl oxygen of Gln203, respectively. While, the pyrrolidine 
ring of the inhibitor shifted from that of the substrate to a position fixed in the 
hydrophobic pocket by approximately 1.4 Å on an average. It is considered that the 
structure of this complex containing the inhibitor strictly bound to the enzyme with a 
covalent bond resembles the structure of the covalent reaction intermediate between 
the enzyme and substrates during catalysis. Although the conformation and positions 
of Tyr604, Val629, Trp632, Tyr639, and Val680 in the PTP39-inhibitor complex 
were not different from those in PTP39, the hydrophobic pocket was slightly enlarged 
by the displacement of Tyr635 and Val680. These conformational changes of Tyr635 
and Val680 were also found in the E636A-inhibitor complex. Therefore, this induced 
fit would inherently occur upon the substrate binding. 
  The location of the S2 site of PTP fit well with that of DPIV, which belongs to the 
same family (Figure 5a and 5b). PTP shows no specificity for residues at the P2 
position; for instance, it has been reported that PTP can hydrolyze substrates 
containing nonpolar aliphatic (Ala, Gly, Pro, and Val), aromatic (Phe), polar 
uncharged (Asn), and charged residues (Glu, Arg, and His) at the P2 position 4, 6. The 
large space of the S2 site would not limit the kind of residue at the P2 position of 
substrates. 
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Function of the glutamate residues at the active site 
DPIV releases an N-terminal Xaa-Pro from substrates containing a Pro at the 
second position from the N-terminus. The N-terminal free amino group of the 
substrate is recognized by two glutamate residues, Glu205* and Glu206* (the * 
denotes the residue from DPIV) at the β-propeller domain 9-12, 17-18. Glu205* and 
Glu206* are found in the helix appended to the fourth blade. This region in PTP 
forms a loop structure, and is three residues shorter than that of DPIV. Only the 
Glu205 corresponding to Glu206* is conserved within this loop6. This Glu205 forms 
a hydrogen bond with the N-terminal amino group of the inhibitor and forms a salt 
bridge with Arg642 from the catalytic domain. Two mutant plasmids expressing 
E205A and E205Q were constructed. However, it was extremely difficult to obtain 
the E205A enzyme protein in a soluble form. Regarding the E205Q mutant, although 
a part of the expressed enzyme was able to be purified as a soluble form, no activity 
was detected using Ala-Phe-Pro-βNA as a substrate (data not shown). These results 
suggested that the Glu205 may play an important role in proper protein folding and 
might contribute to stabilization of the PTP structure through the salt bridge with 
Arg642.  
A residue equivalent to Glu205* could not be found in the active site of PTP. In 
PTP, the Glu636 from the catalytic domain intruded into the active site and formed a 
salt bridge with the inhibitor. In DPIV, Asp663*, corresponding to Glu636 in PTP, is 
located just behind Glu206* and seems to push Glu206* forward. It has been reported 
that dipeptidyl aminopeptidase activity increases in the A647D mutant of human 
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fibroblast activation protein α (FAPα) and decreases in the D663A mutant of human 
DPIV, proteins that belong to the same family 19. FAPα is expressed in epithelial 
cancers and exhibits a dipeptidyl-aminopeptidase activity with 100-fold lower 
catalytic efficiency compared to DPIV 20, 21. Herein, Ala647 is the residue 
corresponding to the Asp663* residue in DPIV. Accordingly, Asp663* must be an 
important residue for the catalytic activity of DPIV. 
In the E636A-inhibitor complex, the inhibitor is bound to the active site in the same 
manner in the PTP39-inhibitor complex except for the contribution of Glu636 (Figure 
3b and 4b). In the former, instead of Glu636, a water molecule was found near the 
corresponding position, located at distances of 2.85 and 2.81 Å from the side-chain 
Gln203 and the inhibitor amino group, respectively. Although the inhibitor was found 
at the same position in the active site, the Ki value of our newly synthesized inhibitor 
against the E636A mutant was 554-fold higher than that against PTP39. Since the 
positions and conformation of residues in the active site largely overlapped between 
the PTP39-inhibitor and E636A-inhibitor complexes, it was simply considered that 
the increase in Ki value resulted from the mutation of E636A. Actually, the E636A 
mutant exhibited very low activity: kcat/KM values in the E636A mutant were 0.83 and 
0.27% those of PTP39 against Gly-Ala-Pro-βNA and Ala-Phe-Pro-βNA, respectively 
(Table 1). Therefore, Glu636 must be involved in substrate recognition by the 
interaction with the N-terminal amino group of the substrate. 
 
Design of specific inhibitor against PTP 
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PTP is considered a potential drug target in treating periodontal disease caused by P. 
gingivalis. The newly synthesized inhibitor of tripeptide boronic acid, 
H-Ala-Ile-pyrrolidin-2-yl boronic acid, mimics the structure of the substrate of PTP. 
Peptide boronic acid is known as an inhibitor of serine proteases, and our inhibitor 
was designed to specifically inhibit the post-proline cleavage. Prolyl amino peptidase 
(PAP), DPIV, and POP are serine peptidases cleaving the post-proline peptide bond. 
Our inhibitor exhibits no inhibition activity against either DPIV from S. maltophilia 
and PAP from B. coagulans. However, POP from A. hydrophila was strongly inhibited 
by the inhibitor with a Ki value of 127 nM. POP is a proline-specific endopeptidase 
found in vertebrates, plants, and bacteria, and is similarly composed of two domains: 
a seven-bladed β-propeller domain and a catalytic domain 9, 22. It has been revealed 
that the side chain of a substrate at the P3 position is accommodated in a space 
between blade-3 and blade-4 inside the POP (PDB codes: 1e8m and 1e8n) 23. The side 
chain of the substrate at the P3 position in POP faces the β-propeller domain, and this 
conformation differs from that of the inhibitor in the PTP39-inhibitor complex (Figure 
5). The blade-3 and -4 in POP correspond to the blade-4 and -5 in the PTP, 
respectively. In PTP, this space is occupied by the loop that contains Glu205 and 
intrudes from blade-4. The methyl group of the inhibitor at the P3 position faces the 
large groove formed between blade-3 and blade-4 and is exposed to solvent. 
Therefore, in the active site of the PTP, there is enough room to accommodate a very 
bulky side-chain of a substrate at the P3 position. Hence, a more specific inhibitor 
against PTP may be developed when a bulky functional group is introduced to the 
Prolyl Tripeptidyl Aminopeptidase from P. gingivalis 
 16
present inhibitor as an N-terminal side-chain instead of Ala. 
 
Materials and Method 
Materials 
     Fast Garnet GBC was obtained from Sigma Chemical Co. DEAE-Toyopearl 
and Toyopearl HW65C were purchased from Tosoh Co., Tokyo, Japan. 
N-Cyclohexyl-2-aminoethanesulfonic acid (CHES), lithium sulfate monohydrate, and 
potassium sodium tartrate tetrahydrate, all of which were used for crystallization, 
were purchased from Nacalai Tesque Inc., Kyoto, Japan. Ala-Phe-Pro--βNA was 
purchased from Wako Pure Chemical Industries, Ltd, Osaka, Japan. Other peptides 
were synthesized according to previously described methods. The pQE30-PTP39 
plasmid, which contains the gene of PTP with an N-terminal truncation of 38 
residues6, and pKF18k plasmid (Takara, Japan) were used for site-directed 
mutagenesis. E. coli M15 (pRep4) (Qiagen) was used for expression. E. coli MV1184 
(ara (lac-proAB) rpsL thi (80 lacZM15) (srl-recA)306::Tn10(tetr) F’[traD36 
proAB+ lacIq lacZM15]) was used for screening the mutated plasmid. A 
Mutan-Super Express Km Kit was purchased from Takara, Japan. The bacteria were 
grown in Luria-Bertani broth (LB-broth) and N-broth. PTP39 6, POP from Aeromonas 
hydrophila 24, DPIV from Stenotrophomonas maltophilia 25 and PAP from Bacillus 
coagulans 26 were purified as described previously.  
 
Inhibitor (H-Ala-Ile-pyrrolidin-2-yl boronic acid) synthesis. 
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The tripeptide-boronic acid type inhibitor was synthesized by the method described 
below (Figure 6). H-Ala-Ile-pyrrolidin-2-yl boronic acid, 5, was synthesized starting 
from N-Boc-pyrrole, 1 27. Thereby the treatment of 1 with lithium (2, 2, 6, 
6)-tetramethylpiperidine (LiTMP) and triethyl borate led to the N-Boc-2-pyrrolyl 
boronic acid, 2. Subsequent hydrogenation utilizing a Pt/C catalyst and addition of (1S, 
2S, 3R, 5S)-pinanediol resulted in the protected boronic acid derivative, (1S, 2S, 3R, 
5S)-pinanediol (Boc-pyrrolidin-2-yl) boronic ester, 3, as a mixture of diastereomers. 
After deprotection of the N-terminal Boc-moiety and coupling to the N-Boc-protected 
dipeptide Boc-Ala-Ile-OH, the resulting product, (1S, 2S, 3R, 5S)-pinanediol 
(Boc-Ala-Ile-pyrrolidin-2-yl) boronic ester, 4, was reacted with phenyl boronic acid. 
Subsequent deprotection of the N-terminus finally resulted in the inhibitor molecule 
as a diastereomeric mixture which was not separated. Details of each step follows. 
N-Boc-2-pyrrolyl boronic acid, 2: TMP (4.4 mL, 26 mmol) was dissolved in 140 mL 
of dry THF and cooled to 198 K. After the addition of nBuLi (16.25 mL, 26 mmol), 
the mixture was stirred for 15 min. A solution of Boc-pyrrole 1 (4.2 mL, 25 mmol) in 
10 mL of THF was added dropwise over a period of 10min followed by triethyl borate 
(15.0 mL, 88 mmol). The solution was stirred for 15 additional min at 198 K and 
overnight at r.t (room temperature). After that, 200 mL of Et2O was added and the 
solution was subjected three treatments with 50 mL of 1M KHSO4 solution followed 
by three extractions by means of 50 mL of NaHCO3 and 50 mL of brine. Then the 
organic layer was dried and the solvent was evaporated. The remaining oil was used 
without further purification. Yield: 2.71 g (51%) 
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(1S, 2S, 3R, 5S)-pinanediol (Boc-pyrrolidin-2-yl) boronic ester, 3: Compound 2 (2.65 
g, 12.56 mmol) was dissolved in 60 mL of dry ethyl acetate, and 0.3 g of Pt/C (10%) 
was added. The mixture was placed in an autoclave and hydrogenated utilizing an 
H2-pressure of 65bar for 4h. After that, the catalyst was removed by filtration and the 
solvent was evaporated, 1.44 g (6.7 mmol) of the remaining glass was dissolved in 50 
mL of absolute Et2O, and 1.25 g (7.4 mmol) of (1S, 2S, 3R, 5S)-pinanediol was added. 
The mixture was stirred for 2h at r.t. The remaining oil was used without further 
purification. Yield: 2.53 g (98%) 
(1S, 2S, 3R, 5S)-pinanediol (Boc-Ala-Ile-pyrrolidin-2-yl) boronic ester, 4: Compound 
3 (4.71 g, 13.5 mmol) was treated with a 160 mL of an ice-cooled saturated solution 
of HCl in Et2O. The solution was stirred overnight at r.t. The solvent was evaporated, 
and the remaining solid was washed by means of 150 mL of a mixture Et2O/pentane 
and dried, giving (1S, 2S, 3R, 5S)-pinanediol (pyrrolidin-2-yl) boronic ester, 
hydrochloride salt, the deprotected form of compound 3, as a white powder. The 
product was used without further purification. Yield: 3.46 g (90%).  
Boc-Ala-Ile-OH (0.30 g, 1 mmol) was dissolved in 9 mL of absolute CHCl3 and 
cooled to 5°C. HOBt (0.15 g, 1 mmol) and 
1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (0.19 g, 1.3 mmol) 
were added, and the mixture was stirred for 30 min. After that, deprotected compound 
3 (0.28 g, 1 mmol) and N-methyl-morpholine (220 mL, 2 mmol) were added and the 
mixture was stirred overnight at r.t. 70 mL of CHCl3 was added and the workup 
procedure was conducted as usual. The remaining oil was purified by means of 
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column chromatography, utilizing a CHCl3/MeOH gradient. Yield: 0.275 g (51%), 
MS m/z 534.2 [M+H]+, 556.3 [M+Na]+ 
H-Ala-Ile-pyrrolidin-2-yl boronic acid, 5: Compound 4 (0.275g, 0.51mmol) was 
dissolved in 20mL of an ice-cooled saturated solution of HCl in Et2O and stirred for 
15min at r.t. and additionally 1h at r.t. The white precipitate was filtered off and dried.  
After that, it was dissolved in 10 mL of 0.1 N aqueous HCl, and phenyl boronic acid 
(0.076g, 0.60mmol) was added. The mixture was stirred for 2h. Over that period, 7mL 
of heptane was added, and then removed when stirring was stopped. The organic 
phases were discarded. The aqueous phase was frozen and lyophilized yielding 5 as a 
white powder. Yield: 0.052g (30%), MS: m/z 300.2 [M+H]+, ESI-FTICR-MS: m/z 
326.22473 ([M+H]+, calc. for C15H29BN3O4
+ 326.22456, glycol adduct), HPLC (214 
nm): r.t. 14.21 min (94.5% HPLC purity), 1HNMR (500MHz, CD3OD)  0.88-1.02 (m, 
7H), 1.15-1.22 (m, 1H), 1,42-1.51 (m, 3H), 1.60-1.68 (m, 2H), 1.83-2.14 (m, 5H), 
2.83-3.01 (m, 1/2H), 3.09-3.11 (m, 1/2H), 3.48-3.60 (m, 2H), 3.82-3.86 (m, 1H), 
3.94-3.99 (m, 1H), 4.43-4.55 (m, 1H). 
      
Construction of mutant enzyme by site-directed mutagenesis 
Site-directed mutation was introduced into the gene by a PCR-based method using 
the Mutan-Super Express Km Kit (Takara, Japan) following the manufacturer’s 
instructions. Briefly, pQE30-PTP39 6 was digested by BamHI and HindIII, and the 
2.1kb fragment containing the gene for PTP39 was subcloned into the same restriction 
sites of pKF18k to produce pKF18k-PTP39, which was then used as the template to 
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produce the mutant plasmids, pFK18k-PTP39-E205Q and pKF18k-PTP39-E636A. 
The oligonucleotides, 5’-TACACCAGCGTCAATTCGGTATC-3’ and 
5’-AATCGATATGCGATTATGTAC-3’, were used as the mutagenic primer for the 
E205Q and E636A mutants, respectively. The mutations were confirmed by 
sequencing analysis with a 3100-Avant Genetic Analyzer. DNA fragments containing 
the specific mutations were prepared by digestion with KpnI and HindIII, and the 
resultant fragments were inserted into the same restriction sites of the plasmid 
pQE30-PTP39 to produce pQE30-PTP39-E205Q and pQE30-PTP39-E636A.  
 
Expression and Purification of E205Q and E636A mutants 
E. coli M15 (pRep4) was transformed with the pQE30-PTP39-E636A plasmid. The 
transformant was grown until A600 reached 0.5 at 303 K in 20 liters of N-broth 
containing 50 g/ml ampicillin. After the addition of 
isopropyl-β-thiogalactopyranoside (IPTG) to a concentration of 0.2 mM, the 
transformant was cultured for an additional 18 h. Approximately 220 mg of the 
E636A mutant was obtained as a purified protein from the harvested cells (61 g wet 
weight) using the same methods including column chromatography on Toyoperal 
HW650C and DEAE-Toyopearl columns (TOSOH) as described for wild-type PTP39 
6. The purity of the isolated enzyme was confirmed by SDS-PAGE. The enzyme 
solution was dialyzed against 20 mM Tris-HCl buffer (pH7.0) containing 0.2 M 
potassium chloride, and concentrated to 35 mg/ml using Centriprep YM-30 
(Millipore). 
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The E205Q mutant was prepared in the same manner as that described for E636A 
except that the plasmid pQE30-PTP39-E205Q was used and the cultivation was 
carried out at 293 K after the IPTG induction. Approximately 45 mg of the purified 
E205Q mutant was obtained from the harvested cells (30 g wet weight). The mutant 
enzyme solution was dialyzed against 0.2 M Potassium chloride with 20 mM 
Tris-HCl buffer (pH7.0), and concentrated to 32 mg/ml using Centriprep YM-30 
(Millipore). 
 
Enzyme activity assay 
The activity of the purified enzyme, PTP39-E636A, was assayed using 
Gly-Ala-Pro-βNA, Ala-Phe-Pro-βNA and Z-Gly-Ala-Pro-βNA as substrates. The 
reaction mixture (1.0 ml) consisted of 0.8 ml of 20 mM Tris–HCl buffer (pH 7.0), 0.1 
ml of enzyme solution, and 0.1 ml of substrate solution. After 10 min incubation at 
310 K (unless otherwise indicated), the reaction was stopped by adding 0.5 ml of Fast 
Garnet GBC (1 mg/ml) solution containing 10% (v/v) Triton X-100 in 1 M sodium 
acetate buffer (pH 4.0). The absorbance at 550 nm was measured after 20 min. To 
determine the KM values, the concentration of substrate was varied. Lineweaver–Burk 
plots were used to calculate the KM and apparent Vmax values. The enzyme 
concentrations were estimated from the molar extinction coefficient, 11,900. The kcat 
value was calculated using a molecular mass of 79,393. 
 
Inhibition activity of the synthesized inhibitor 
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The reaction mixture (1.0 ml) consisted of 0.7 ml of 20 mM Tris–HCl buffer (pH 
7.0), 0.1 ml of enzyme solution, and 0.1 ml of inhibitor solution. After incubation at 
310 K for 5 minutes, 0.1 ml of the substrate solution was added to initiate the reaction, 
and incubation for 10 min at 310 K followed. The reaction was terminated by the 
addition of 0.5 ml Fast Garnet GBC (1 mg/ml) solution containing 10% (v/v) Triton 
X-100 in 1 M sodium acetate buffer (pH 4.0). The absorbance at 550 nm was 
measured after 20 min. To determine the Ki value, the concentrations of substrate and 
inhibitor were varied. Dixon plots were used to calculate Ki values.  
 
Crystallization and data collection 
Crystallization of the PTP39 complexed with the inhibitor (PTP39-inhibitor 
complex) was carried out at 293 K by the hanging-drop vapor-diffusion method. The 
same volume of the reservoir solution (1.1 M potassium/sodium tartrate, 200 mM 
lithium sulfate, and 100 mM CHES buffer, pH 9.0) and the protein solution (18 mg/ml 
enzyme solution containing 2 mM of the inhibitor) were mixed. After 10 days 
incubation, hexagonal crystals grew to dimensions of 0.2 x 0.2 x 0.2 mm; they 
consisted of isomorphous crystals with a ligand-free enzyme and belonged to the 
space group P6322 with the following cell dimensions: a=150.1, b=150.1, c=161.0 Å, 
γ= 120°. The crystallizations of the E636A mutant complexed with the inhibitor 
(E636A-inhibitor complex) and the E636A mutant alone were carried out using the 
same conditions as for PTP39. 
The diffraction data for the PTP39-inhibitor complex, the E636A-inhibitor complex 
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and the E636A mutant were collected to 2.20, 2.00, and 1.95 Å resolution, 
respectively, at 100 K using a wavelength of 1.000 Å from the synchrotron radiation 
source. All data were collected by total oscillation range of 180° with the φ oscillation 
of 0.5° using station BL5 at the Photon Factory (Tsukuba, Japan). For data collection 
under cryogenic conditions, the crystals were soaked for several minutes in a prepared 
solution containing 30%(v/v) glycerol, 1.1 M potassium sodium tartrate, 200 mM 
lithium sulfate, and 100 mM CHES buffer (pH 9.0). The crystals were mounted in a 
nylon loop and flash-cooled at 100 K. All data were processed and scaled by 
HKL2000 28, and are summarized in Table 2. 
 
Structure determination and refinement 
The scaling of all data and the map calculations was performed using the CCP4 
program suite 29, and the model building was performed using the programs 
XTALVIEW 30 and COOT 31. The coordinate of the ligand-free PTP (PDB code: 2d5l) 
was used for the initial model-building. The structure of the PTP-inhibitor complex 
was refined by simulated annealing and energy minimization with the program CNS 32 
using the data obtained from 20 to 2.20 Å resolution. The structure was examined by 
inspecting the composite omit map. The difference Fourier map clearly displayed a 
residual electron density corresponding to the inhibitor bound at the active site. This 
Fourier map was assigned to R-configured form of two diastereomer at the 
Cα-position of the pyrrolidine ring of the inhibitor on the basis of its shape. 
Refinement using REFMAC 29 and model rebuilding were alternately carried out over 
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several cycles; then water molecules were selected on the basis of the peak height and 
the distance criteria from the difference map. The water molecules whose thermal 
factors exceeded 60 Å after refinement were removed from the list. Further model 
building and refinement cycles gave an R-factor of 18.6% and an R-free value of 
22.0% using 51,107 reflections from 20 to 2.2 Å resolution. The maximal thermal 
factor of the water molecules was 58.5 Å2. 
The same refinement procedure was applied to the E636A mutant and the 
E636-inhibitor complex. The difference Fourier map displayed a residual electron 
density corresponding to the inhibitor in the E636A-inhibitor complex. In the E636A 
mutant, the Fourier map showed residual electron density in the hydrophobic pocket, 
which accommodates a proline residue of the substrate. This residual electron density 
was assigned to glycerol as a cryoprotectant from size, shape, and peak height. A 
refinement cycle including simulated annealing and energy minimization, selection of 
water molecules, and model-rebuilding gave R-factors of 18.8 and 18.5 % and R-free 
values of 21.3 and 21.2 % using 66,749 and 72,472 reflections at 20 to 2.0 and 1.95 Å 
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Figure 1 The structure of prolyl tripeptidyl aminopeptidase 
(a) One of the dimers of the PTP39-inhibitor complex is shown as a ribbon model and 
the other is shown as protein-surface model. The α-helices and β-strands from the 
β-propeller domain are represented by blue and cyan, and those from the catalytic 
domain are represented by orange and red, respectively. The protein surface is 
indicated by cyan and orange on the respective domains. This diagram was drawn 
using the program PYMOL (http://www.pymol.org/), MOLSCRIPT 33, and 
RASTER3D 34. (b) Stereo diagram of the -propeller domain in the PTP39-inhibitor 
complex from the top view. Each propeller blade is separated by color with 
numbering. Our synthesized inhibitor is shown as a stick model. (c) A stereo diagram 
superimposing the subunits of the PTP-inhibitor complex, the E636A mutant, and the 
E636A-inhibitor complex onto PTP39 (PDB code: 2d5l). The Cα traces of PTP39, the 
PTP39-inhibitor complex, the E636A mutant, and the E636A-inhibitor complex are 
represented by black, green, blue, and red lines, respectively. The stick models of the 
inhibitor in the PTP39- and E636A-inhibitor complexes are designated with the same 
color as each Cα-trace lines. Diagram was drawn using the program MOLSCRIPT 33. 
 
Figure 2 The inhibitor bound to the active site with the Fo-Fc omit map contoured at 
2 σ levels  
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Ribbon-and-stick models of the active-site structure in the PTP39-inhibitor (a) and 
E636A-inhibitor (b) complexes. Each inhibitor is shown as a ball-and-stick model.  
Diagrams were drawn with the program POVSCRIPT+ 35 and rendered with the 
program POVRAY (http://www.povray.org). 
 
Figure 3 Stereo diagrams of superimposed structures of the active site in prolyl 
tripeptidyl aminopeptidase 
(a) A ribbon-and-stick model of the active site superimposing the S603A-substrate 
and PTP39-inhibitor complexes onto PTP39 with the least-square method; the 
structures are represented by pink, green, and grey, respectively. The substrate and 
inhibitor are shown as a ball-and-stick model. (b) A ribbon-and-stick model 
superimposing the E636A mutant and the E636A-inhibitor complex onto the 
PTP39-inhibitor complex; the structures are represented by blue, red, and green, 
respectively.  
 
Figure 4 Scheme diagram of the active site binding the inhibitor 
These diagrams schematically represent protein-inhibitor interactions in the 
PTP39-inhibitor (a) and E636A-inhibitor (b) complexes. Diagrams were drawn based 
on output from the program LIGPLOT 36.  
 
Figure 5 Surface diagram of the active site at the POP family 
(a) PTP39 complexed with our synthesized inhibitor (b) DPIV complexed with 
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1-iodo-phenylalanyl-(2S)-pyrrolidine-2-yl-methylamine (PDB code: 1orw) (c) S554A 
mutated POP complex with 6-aminobenzoyl-Gly-Phe-Gly-Pro-Phe-Gly. Surface of 
the β-propeller and catalytic domains were represented by blue and orange, 
respectively. These diagrams were drawn using the program PYMOL 
(http://www.pymol.org/). 
 
Figure 6 Scheme of synthesis for H-Ala-Ile-pyrrolidin-2-yl boronic acid 
Synthesized inhibitor was mixture of two diastereomers, which differ in the chiral 
carbon indicated asterisks (*).  
 
FOOT NOTE 
The atomic coordinates and structure factors for PTP39 complexd with the inhibitor, 
E636A mutant, and E636A mutant complexed with the inhibitor (PDB code 2EEP, 
2Z3W, 2Z3Z) have been deposited in the Worldwide Protein Data Bank (wwPDB; 
http://www.wwpdb.org), the Protein Data Bank Japan at the Institute for Protein 
Research in Osaka University (PDBj; http://www.pdbj.org/) 
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1 The abbreviations used are: PTP, prolyl tripeptidyl aminopeptidase: POP, prolyl 
oligopeptidase; DPIV, dipeptidyl aminopeptidase IV; PTP39, PTP truncated the 38 
N-terminal residues; --βNA, -β-naphtykamide; -TBODA, 2-ter-butyl-[1, 3, 
4]-oxadiazole; PAP, prolyl aminopeptidase; CHES, 
N-cychlohexyl-2-aminoethansulfonic acid; TMP, (2, 2, 6, 6,)-tetramethylpeperidine; 
IPTG, isopropyl-β-thiogalactopyranoside;   
Prolyl Tripeptidyl Aminopeptidase from P. gingivalis 
 34
Table 1 Kinetic parameters of the PTP39 and E636A mutant catalyzed hydrolysis  






















Gly-Ala-Pro-NA 0.42 354 843 0.38 2.65 6.97 
Ala-Phe-Pro-NA 0.17 511 3006 0.85 6.80 8.0 
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Table 2  Data collection and refinement statistics 
 
  PTP39-inhibitor E636A mutant E636A-inhibitor 
  complex  complex 
Data collection 
 Space group P6322 P6322 P6322 
 Cell parameter 
  a, b (Å) 150.1 149.7 149.8 
  c (Å) 161.0 160.9 161.5 
 Resolution range (Å) 50-2.2 (2.28-2.20) 50-2.0 (2.07-2.00) 50-1.95 (2.02-1.95)
 Number of unique reflections 54749 (5385) 71966 (7035) 77828 (7590) 
 Completeness (%) 99.9 (100) 99.9 (99.6) 99.8 (99.0) 
 Redundancy 20.8 (19.9) 20.4 (19.5) 20.2 (18.7) 
 Rmerge 0.069 (0.281) 0.064 (0.315) 0.062 (0.306) 
 Mean I/σ(I) 58.3 (9.1) 61.6 (7.5) 64.0 (7.0) 
 Willson B (Å2) 37.6 30.9 29.6 
Refinement 
 Resolution range (Å) 20-2.2 20-2.0 20-1.95 
 R-factor 0.186 0.188 0.185 
 Rfree 0.220 0.213 0.212 
 Average B-factor 
 main chain (Å2) 41.2 35.2 33.1 
 side chain (Å2) 41.8 36.2 34.2 
 waters (Å2) 39.7 40.6 40.3 
 inhibitor (Å2) 31.3  29.9 
Rmerge = Σhkl Σi | I hkl,i - <I hkl> | / Σ hkl Σ i I hkl,i , where I = observed intensity and <I> = average intensity for 
multiple measurements. 
Values in parentheses refer to the last resolution shell.
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Figure 6 
 
 
 
